Dr. Bassi’s presentations focus on the positive effects of ventilating ARDS patients using transvenous diaphragm neurostimulation, showcasing the benefits of Lungpacer Therapy on lung mechanics, hemodynamics, and brain connectivity. The data also confirms the feasibility of using diaphragm neurostimulation to provide respiratory and cardiovascular support during military medevac and CASEVAC scenarios.
Lungpacer Medical’s Lead Research Scientist Thiago Bassi, MD, PhD presents data at the 2024 MHSRS (Military Health System Research Symposium)
- August 28, 2024